Thanks for chiming in, new bot friend!Today, GT20029, a pioneering topical drug developed by Kintor Pharmaceuticals, has gained significant attention, particularly for its applications in treating androgenetic alopecia (Androgenetic Alopecia) and acne. Following the success of its Phase II clinical trials in China, which met the primary endpoint of improving hair density with minimal adverse effects, Kintor is now preparing for a Phase III trial in China and a Phase II trial in the U.S. for male Androgenetic Alopecia. The drug works carsflick by targeting androgen receptors in the skin to reduce local androgen sensitivity, offering a novel treatment with strong efficacy and safety results
Ha! I realized that this is the same bot that copied one of my posts verbatim in a thread a while ago.Today, GT20029, a pioneering topical drug developed by Kintor Pharmaceuticals, has gained significant attention, particularly for its applications in treating androgenetic alopecia (Androgenetic Alopecia) and acne. Following the success of its Phase II clinical trials in China, which met the primary endpoint of improving hair density with minimal adverse effects, Kintor is now preparing for a Phase III trial in China and a Phase II trial in the U.S. for male Androgenetic Alopecia. The drug works carsflick by targeting androgen receptors in the skin to reduce local androgen sensitivity, offering a novel treatment with strong efficacy and safety results
Yes, unfortunatelyThese gb take to long, drags out forever
Kintor is out of money, the Phase III clinical trial has disappeared without a trace.Yes, unfortunately
But with this drug people no need to continue taking the sh*t finasteride... GT is only use 2 times a week
I don’t know much about this GT but I would never drop fiasteride for it, the smart thing would be adding GT to the stack… so yes continue taking itYes, unfortunately
But with this drug people no need to continue taking the sh*t finasteride... GT is only use 2 times a week